跳至主要内容
临床试验/CTIS2024-516379-34-00
CTIS2024-516379-34-00进行中(未招募)1 期

Investigator led, double-masked, multicentre, randomized clinical trial for the comparison of atropine 0.5% versus atropine 0.05% eye drops for the prevention of myopia progression in Dutch children - 7098

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)0 个研究点目标入组 550 人开始时间: 2024年7月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • Children aged 6 to = 11 years with bilateral myopia, Onset of myopia = 4 years of age, History of myopia progression., SER of at least -1.00D and no greater than -6.00D in each eye measured using cycloplegic auto refraction, Intraocular pressure < 21 mm Hg in each eye

排除标准

  • Allergy to atropine, History of amblyopia or strabismus, glaucoma or retinal dystrophy or systemic disorder that predisposes to severe myopia (e.g., Marfan syndrome, retinitis pigmentosa, Stickler syndrome, retinopathy of prematurity)., Prior myopia control treatment (Atropine, ortho-keratology, multifocal contact lenses, Glaucoma

研究者

相似试验

招募中
3 期
Investigator led, double-masked, multicenter, randomized clinical trial for the comparison of Atropine 0.5% versus Atropine 0.05% eye drops for the prevention of myopia progression in Dutch children.nearsightedness10047518Myopia
NL-OMON55937Erasmus MC, Universitair Medisch Centrum Rotterdam550
进行中(未招募)
不适用
A multicenter, Investigator - masked, parallel-group, randomized study of the efficacy and safety of loteprednol etabonate 0.5% eyedrops versus dexamethasone 0.1% eyedrops in the treatment of ocular inflammation following cataract surgery. - Study#541-Lteprednol etabonate vs DexamethasoneSubjects scheduled to undergo cataract surgeryMedDRA version: 9.1Level: SOCClassification code 10015919Term: Eye disorders
EUCTR2007-005621-30-ITBAUSCH&LOMB190
进行中(未招募)
不适用
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1 % Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.Prevention of ocular inflammation in adults patients undergoing cataract surgeryMedDRA version: 9.1Level: HLTClassification code 10030045Term: Ocular infections, inflammations and associated manifestations
EUCTR2007-004686-18-DEDr. Gerhard Mann chem.-pharm. Fabrik GmbH120
进行中(未招募)
不适用
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1% Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.Prevention of ocular inflammation in adults patients undergoing cataract surgery.
EUCTR2007-004686-18-PTBausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH120
进行中(未招募)
1 期
A multicenter, Investigator-Masked, Parallel Group, Randomized, Study of the Efficacy and Safety of Indomethacin 0.1% Eyedrops Compared with Ketorolac 0.5% Eyedrops in the Ocular Inflammation After Cataract Surgery.
EUCTR2007-004686-18-FRBausch&Lomb Dr Gerhard Mann chem.-Fabrik GmbH123